An algorithm for utilizing peripheral blood CD34 count as a predictor of the need for plerixafor in autologous stem cell mobilization-cost-effectiveness analysis-Reference-Cited by-同舟云学术

An algorithm for utilizing peripheral blood CD34 count as a predictor of the need for plerixafor in autologous stem cell mobilization-cost-effectiveness analysis

Published:2013-02-21 Issue:4 Volume:28 Page:293-300
ISSN:0733-2459
Container-title:Journal of Clinical Apheresis
language:en
Short-container-title:J. Clin. Apheresis

Author:

Abusin Ghada A.¹,Abu-Arja Rolla F.¹,Gingrich Roger D.²,Silverman Margarida D.²,Zamba Gideon K. D.³,Schlueter Annette J.⁴

Affiliation:

1. Department of Pediatrics; Division of Hematology; Oncology and Bone Marrow Transplantation; University of Iowa Carver College of Medicine; Iowa City; Iowa

2. Department of Internal Medicine; Division of Hematology; Oncology and Blood & Marrow Transplantation; University of Iowa Carver College of Medicine; Iowa City; Iowa

3. Department of Biostatistics; University of Iowa Carver College of Medicine; Iowa City; Iowa

4. Department of Pathology; University of Iowa Carver College of Medicine; Iowa City; Iowa

Publisher

Wiley

Subject

Hematology,General Medicine

Reference30 articles.

1. Current status of stem cell mobilization;Gertz;Br J Haematol,2010

2. Failure to achieve a threshold dose of CD34+ CD110+ progenitor cells in the graft predicts delayed platelet engraftment after autologous stem cell transplantation for multiple myeloma;Wallington-Beddoe;Biol Blood Marrow Transplant,2009

3. International Myeloma Working Group (IMWG) consensus statement and guidelines regarding the current status of stem cell collection and high-dose therapy for multiple myeloma and the role of plerixafor (AMD 3100);Giralt;Leukemia,2009

4. Transplanted CD34(+) cell dose is associated with long-term platelet count recovery following autologous peripheral blood stem cell transplant in patients with non-Hodgkin lymphoma or multiple myeloma;Stiff;Biol Blood Marrow Transplant,2011

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Use of subgroup‐specific hematopoietic stem cell collection efficiencies to improve truncation calculations for large‐volume leukapheresis procedures;Journal of Clinical Apheresis;2023-08

2. EVALUATION OF AN ALGORITHM FOR STEM CELL MOBILIZATION WITH COMBINED ON-DEMAND PLERIXAFOR USE IN AUTOLOGOUS PERIPHERAL BLOOD STEM CELL COLLECTION;Japanese Journal of Transfusion and Cell Therapy;2022-12-20

3. Plerixafor strategies for autologous hematopoietic cell transplant mobilization: A comparison of efficacy and cost;Transfusion and Apheresis Science;2021-10

4. Single‐center results reporting improved hematopoietic stem cell mobilization success in pediatric and young adult patients with solid tumors and lymphoma;Pediatric Blood & Cancer;2021-09-07

5. Evaluation of the Effects of Human Dental Pulp Stem Cells on the Biological Phenotype of Hypertrophic Keloid Fibroblasts;Cells;2021-07-16